These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29114847)

  • 41. Diagnostic accuracy and applicability of intestinal auto-antibodies in the wide clinical spectrum of coeliac disease.
    De Leo L; Bramuzzo M; Ziberna F; Villanacci V; Martelossi S; Leo GD; Zanchi C; Giudici F; Pandullo M; Riznik P; Mascio AD; Ventura A; Not T
    EBioMedicine; 2020 Jan; 51():102567. PubMed ID: 31901853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
    Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis.
    Carroccio A; Di Prima L; Pirrone G; Scalici C; Florena AM; Gasparin M; Tolazzi G; Gucciardi A; Sciumè C; Iacono G
    Clin Chem; 2006 Jun; 52(6):1175-80. PubMed ID: 16574764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.
    Giersiepen K; Lelgemann M; Stuhldreher N; Ronfani L; Husby S; Koletzko S; Korponay-Szabó IR;
    J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):229-41. PubMed ID: 22266486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.
    Kaukinen K; Sulkanen S; Mäki M; Collin P
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):311-5. PubMed ID: 11953698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency.
    Lenhardt A; Plebani A; Marchetti F; Gerarduzzi T; Not T; Meini A; Villanacci V; Martelossi S; Ventura A
    Dig Liver Dis; 2004 Nov; 36(11):730-4. PubMed ID: 15571003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues.
    Korponay-Szabó IR; Laurila K; Szondy Z; Halttunen T; Szalai Z; Dahlbom I; Rantala I; Kovács JB; Fésüs L; Mäki M
    Gut; 2003 Feb; 52(2):199-204. PubMed ID: 12524400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistologic analysis of the duodenal bulb: a new method for celiac disease diagnosis in children.
    De Leo L; Villanacci V; Ziberna F; Vatta S; Martelossi S; Di Leo G; Zanchi C; Bramuzzo M; Giudici F; Ventura A; Not T
    Gastrointest Endosc; 2018 Sep; 88(3):521-526. PubMed ID: 29807020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease.
    Caruso R; Marafini I; Del Vecchio Blanco G; Fina D; Paoluzi OA; Colantoni A; Sedda S; Pallone F; Monteleone G
    Dig Liver Dis; 2014 Apr; 46(4):323-9. PubMed ID: 24394601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low prevalence of IgA anti-transglutaminase 1, 2, and 3 autoantibodies in children with atopic dermatitis.
    Ress K; Teesalu K; Annus T; Putnik U; Lepik K; Luts K; Uibo O; Uibo R
    BMC Res Notes; 2014 May; 7():310. PubMed ID: 24885370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease.
    Salmi TT; Collin P; Järvinen O; Haimila K; Partanen J; Laurila K; Korponay-Szabo IR; Huhtala H; Reunala T; Mäki M; Kaukinen K
    Aliment Pharmacol Ther; 2006 Aug; 24(3):541-52. PubMed ID: 16886921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility.
    Simell S; Kupila A; Hoppu S; Hekkala A; Simell T; Ståhlberg MR; Viander M; Hurme T; Knip M; Ilonen J; Hyöty H; Simell O
    Scand J Gastroenterol; 2005 Oct; 40(10):1182-91. PubMed ID: 16265775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Injection of celiac disease patient sera or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease.
    Kalliokoski S; Caja S; Frias R; Laurila K; Koskinen O; Niemelä O; Mäki M; Kaukinen K; Korponay-Szabó IR; Lindfors K
    J Mol Med (Berl); 2015 Jan; 93(1):51-62. PubMed ID: 25209899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of screening for coeliac disease in children with juvenile idiopathic arthritis.
    Öman A; Hansson T; Carlsson M; Berntson L
    Acta Paediatr; 2019 Apr; 108(4):688-693. PubMed ID: 30265401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression.
    Brusco G; Muzi P; Ciccocioppo R; Biagi F; Cifone MG; Corazza GR
    Clin Exp Immunol; 1999 Dec; 118(3):371-5. PubMed ID: 10594554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies.
    Caja S; Myrsky E; Korponay-Szabo IR; Nadalutti C; Sulic AM; Lavric M; Sblattero D; Marzari R; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
    Scand J Gastroenterol; 2010 Apr; 45(4):421-7. PubMed ID: 20095873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
    Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM
    Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoantibodies from patients with celiac disease inhibit transglutaminase 2 binding to heparin/heparan sulfate and interfere with intestinal epithelial cell adhesion.
    Teesalu K; Panarina M; Uibo O; Uibo R; Utt M
    Amino Acids; 2012 Feb; 42(2-3):1055-64. PubMed ID: 21847613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
    Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S;
    Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.